Pooling breast cancer datasets has a synergetic effect on classification performance and improves signature stability

[1]  Catherine Charbonnel,et al.  Prediction of metastatic relapse in node-positive breast cancer: establishment of a clinicogenomic model after FEC100 adjuvant regimen , 2008, Breast Cancer Research and Treatment.

[2]  Donald Geman,et al.  Merging microarray data from separate breast cancer studies provides a robust prognostic test , 2008, BMC Bioinformatics.

[3]  O. Marín,et al.  Chemokine Signaling Controls Intracortical Migration and Final Distribution of GABAergic Interneurons , 2008, The Journal of Neuroscience.

[4]  M. Dowsett,et al.  International Web-based consultation on priorities for translational breast cancer research , 2007, Breast Cancer Research.

[5]  Yusuke Nakamura,et al.  Activation of KIF4A as a Prognostic Biomarker and Therapeutic Target for Lung Cancer , 2007, Clinical Cancer Research.

[6]  K. Gunsalus,et al.  Network modeling links breast cancer susceptibility and centrosome dysfunction. , 2007, Nature genetics.

[7]  Yusuke Nakamura,et al.  Involvement of kinesin family member 2C/mitotic centromere‐associated kinesin overexpression in mammary carcinogenesis , 2007, Cancer science.

[8]  T. Ideker,et al.  Network-based classification of breast cancer metastasis , 2007, Molecular systems biology.

[9]  Harry Bartelink,et al.  Gene expression profiling and histopathological characterization of triple-negative/basal-like breast carcinomas , 2007, Breast Cancer Research.

[10]  R. Hruban,et al.  Class III β‐tubulin, a marker of resistance to paclitaxel, is overexpressed in pancreatic ductal adenocarcinoma and intraepithelial neoplasia , 2007, Histopathology.

[11]  Yi Zhang,et al.  Pathway analysis of gene signatures predicting metastasis of node-negative primary breast cancer , 2007, BMC Cancer.

[12]  J. Baselga,et al.  4E-binding protein 1: a key molecular "funnel factor" in human cancer with clinical implications. , 2007, Cancer research.

[13]  I. Ellis,et al.  An immune response gene expression module identifies a good prognosis subtype in estrogen receptor negative breast cancer , 2007, Genome Biology.

[14]  John D. Storey,et al.  Capturing Heterogeneity in Gene Expression Studies by Surrogate Variable Analysis , 2007, PLoS genetics.

[15]  Donald Geman,et al.  Large-scale integration of cancer microarray data identifies a robust common cancer signature , 2007, BMC Bioinformatics.

[16]  C. Sotiriou,et al.  Taking gene-expression profiling to the clinic: when will molecular signatures become relevant to patient care? , 2007, Nature Reviews Cancer.

[17]  T. Corson,et al.  KIF14 Messenger RNA Expression Is Independently Prognostic for Outcome in Lung Cancer , 2007, Clinical Cancer Research.

[18]  J. Bergh,et al.  Strong Time Dependence of the 76-Gene Prognostic Signature for Node-Negative Breast Cancer Patients in the TRANSBIG Multicenter Independent Validation Series , 2007, Clinical Cancer Research.

[19]  J. Bergh,et al.  Definition of clinically distinct molecular subtypes in estrogen receptor-positive breast carcinomas through genomic grade. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[20]  K. Basso,et al.  Gene dosage alterations revealed by cDNA microarray analysis in cervical cancer: Identification of candidate amplified and overexpressed genes , 2007, Genes, chromosomes & cancer.

[21]  I. Ellis,et al.  A gene-expression signature to predict survival in breast cancer across independent data sets , 2007, Oncogene.

[22]  Lajos Pusztai,et al.  Determination of oestrogen-receptor status and ERBB2 status of breast carcinoma: a gene-expression profiling study. , 2007, The Lancet. Oncology.

[23]  Yusuke Nakamura,et al.  Involvement of maternal embryonic leucine zipper kinase (MELK) in mammary carcinogenesis through interaction with Bcl-G, a pro-apoptotic member of the Bcl-2 family , 2007, Breast Cancer Research.

[24]  J. Mackey,et al.  Class III β-Tubulin Expression and Benefit from Adjuvant Cisplatin/Vinorelbine Chemotherapy in Operable Non–Small Cell Lung Cancer: Analysis of NCIC JBR.10 , 2007, Clinical Cancer Research.

[25]  Kikuya Kato,et al.  Possible involvement of CCT5, RGS3, and YKT6 genes up-regulated in p53-mutated tumors in resistance to docetaxel in human breast cancers , 2007, Breast Cancer Research and Treatment.

[26]  J. Baselga,et al.  4E-Binding Protein 1, A Cell Signaling Hallmark in Breast Cancer that Correlates with Pathologic Grade and Prognosis , 2007, Clinical Cancer Research.

[27]  Ajay N. Jain,et al.  Genomic and transcriptional aberrations linked to breast cancer pathophysiologies. , 2006, Cancer cell.

[28]  F. Eusebi,et al.  The Chemokine CX3CL1 Reduces Migration and Increases Adhesion of Neurons with Mechanisms Dependent on the β1 Integrin Subunit1 , 2006, The Journal of Immunology.

[29]  I. Ellis,et al.  A consensus prognostic gene expression classifier for ER positive breast cancer , 2006, Genome Biology.

[30]  Beate Sick,et al.  Quality assessment of Affymetrix GeneChip data. , 2006, Omics : a journal of integrative biology.

[31]  T. Corson,et al.  KIF14 mRNA expression is a predictor of grade and outcome in breast cancer , 2006, International journal of cancer.

[32]  E. Martinelli,et al.  Class III β-Tubulin Overexpression Is a Marker of Poor Clinical Outcome in Advanced Ovarian Cancer Patients , 2006, Clinical Cancer Research.

[33]  Patrick Kemmeren,et al.  Multiple robust signatures for detecting lymph node metastasis in head and neck cancer. , 2006, Cancer research.

[34]  Daniel Q. Naiman,et al.  Robust prostate cancer marker genes emerge from direct integration of inter-study microarray data , 2005, Bioinform..

[35]  L. Holmberg,et al.  Gene expression profiling spares early breast cancer patients from adjuvant therapy: derived and validated in two population-based cohorts , 2005, Breast Cancer Research.

[36]  Cor J. Veenman,et al.  A protocol for building and evaluating predictors of disease state based on microarray data , 2005, Bioinform..

[37]  P. Hall,et al.  An expression signature for p53 status in human breast cancer predicts mutation status, transcriptional effects, and patient survival. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[38]  C. Dumontet,et al.  Expression of Class III β-Tubulin Is Predictive of Patient Outcome in Patients with Non–Small Cell Lung Cancer Receiving Vinorelbine-Based Chemotherapy , 2005, Clinical Cancer Research.

[39]  Rafael A. Irizarry,et al.  Bioinformatics and Computational Biology Solutions using R and Bioconductor , 2005 .

[40]  Andy J. Minn,et al.  Genes that mediate breast cancer metastasis to lung , 2005, Nature.

[41]  C. Dumontet,et al.  Expression of class III {beta}-tubulin is predictive of patient outcome in patients with non-small cell lung cancer receiving vinorelbine-based chemotherapy. , 2005, Clinical cancer research : an official journal of the American Association for Cancer Research.

[42]  Hung-Hsiang Yu,et al.  Semaphorin signaling guides cranial neural crest cell migration in zebrafish. , 2005, Developmental biology.

[43]  J. Foekens,et al.  Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer , 2005, The Lancet.

[44]  Stefan Michiels,et al.  Prediction of cancer outcome with microarrays: a multiple random validation strategy , 2005, The Lancet.

[45]  Yusuke Nakamura,et al.  Down-regulation of RAB6KIFL/KIF20A, a kinesin involved with membrane trafficking of discs large homologue 5, can attenuate growth of pancreatic cancer cell. , 2005, Cancer research.

[46]  D. Koller,et al.  A module map showing conditional activity of expression modules in cancer , 2004, Nature Genetics.

[47]  Eytan Domany,et al.  Outcome signature genes in breast cancer: is there a unique set? , 2004, Breast Cancer Research.

[48]  T. Speed,et al.  Summaries of Affymetrix GeneChip probe level data. , 2003, Nucleic acids research.

[49]  Yudong D. He,et al.  A Gene-Expression Signature as a Predictor of Survival in Breast Cancer , 2002 .

[50]  R. Tibshirani,et al.  Diagnosis of multiple cancer types by shrunken centroids of gene expression , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[51]  Geoffrey J McLachlan,et al.  Selection bias in gene extraction on the basis of microarray gene-expression data , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[52]  M. Heydtmann,et al.  The nature of truth: Simpson's Paradox and the limits of statistical data. , 2002, QJM : monthly journal of the Association of Physicians.

[53]  Yudong D. He,et al.  Gene expression profiling predicts clinical outcome of breast cancer , 2002, Nature.

[54]  S. Lo,et al.  Tensin1 and a previously undocumented family member, tensin2, positively regulate cell migration , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[55]  E. Martinelli,et al.  Class III beta-tubulin overexpression is a marker of poor clinical outcome in advanced ovarian cancer patients. , 2006, Clinical cancer research : an official journal of the American Association for Cancer Research.

[56]  Van,et al.  A gene-expression signature as a predictor of survival in breast cancer. , 2002, The New England journal of medicine.